Phathom Pharmaceuticals Inc. is a clinical-stage biopharmaceutical firm based in Florham Park, New Jersey, focused on advancing innovative therapies for gastrointestinal disorders. Leveraging a robust pipeline aimed at addressing significant unmet medical needs in severe gastrointestinal conditions, the company is committed to rigorous clinical development. With several potential product launches on the horizon, Phathom is strategically positioned for substantial growth, presenting an appealing opportunity for institutional investors seeking exposure to transformative advancements in the biopharmaceutical sector. Show more

Location: 100 CAMPUS DRIVE, FLORHAM PARK, NJ, UNITED STATES, 07932, Florham Park, NJ, 07932, USA | Website: https://www.phathompharma.com | Industry: BIOTECHNOLOGY | Sector: HEALTHCARE

Market Cap

968.1M

52 Wk Range

$2.21 - $18.31

Previous Close

$12.41

Open

$12.82

Volume

950,612

Day Range

$12.20 - $12.94

Enterprise Value

1.107B

Cash

135.2M

Avg Qtr Burn

-14.12M

Insider Ownership

4.70%

Institutional Own.

77.28%

Qtr Updated

09/30/25

Only showing assets and stage. See catalyst data with a free or premium account. Unlock more data with a free account.

Drug & Indication	Stage & Event	Catalyst Date
VOQUEZNA (Vonoprazan) (Potassium competitive acid blocker) Details Bacterial infection	Approved Quarterly sales	Some catalyst date You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details.Sign up now.
VOQUEZNA (Vonoprazan)(Potassium competitive acid blocker) Details Intestinal infection, Gastroesophageal reflux disease, Esophagitis	Approved Quarterly sales	Some catalyst date You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details.Sign up now.
VOQUEZNA® (vonoprazan)(potassium competitive acid blocker) Details Gastroesophageal reflux disease	Approved Quarterly sales	Some catalyst date You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details.Sign up now.
VOQUEZNA® (vonoprazan)(potassium competitive acid blocker) Details Gastroesophageal reflux disease	Phase 3 Initiation	Some catalyst date You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details.Sign up now.
VOQUEZNA® (Vonoprazan)(potassium competitive acid blocker) Details Eosinophilic Esophagitis	Phase 2 Data readout	Some catalyst date You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details.Sign up now.